Literature DB >> 16028098

shRNA-targeted hTERT suppress cell proliferation of bladder cancer by inhibiting telomerase activity.

Lin Zou1, Penghui Zhang, Chunli Luo, Zhiguang Tu.   

Abstract

RNA interference (RNAi) has demonstrated profound prospect in human gene research. hTERT, the rate-limiting component of telomerase activity, is highly expressed in bladder cancer cells. Here, we investigated the anti-proliferation effects of small hairpin interfering RNA (shRNA)-targeted hTERT gene on bladder cancer in vitro and in vivo. The results showed that ph2-shRNA, the most-effective vector carrying shRNA-targeted hTERT, could significantly inhibit the cell proliferation by down-regulating hTERT expression, decreasing telomerase activity, decreasing cell number of S phase, increasing the cell number of G0/G1 phase in T24 cells and xenograft tumor tissues, and attenuate the tumor growth of xenograft mice model compared with controls. Our results demonstrate that hTERT-directed shRNAs are potent inhibitors of bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16028098     DOI: 10.1007/s00280-005-0056-x

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  3 in total

1.  Effect of TERT on the growth of fibrosarcoma via caspase-3, survivin and PKB.

Authors:  Qiuye Ma; Yidong Yu; Linlin Dai; Xuehua Qu; Shan Cong; Hongsuo Liang
Journal:  Oncol Lett       Date:  2017-06-13       Impact factor: 2.967

2.  Effects of combined siRNA-TR and -TERT on telomerase activity and growth of bladder transitional cell cancer BIU-87 cells.

Authors:  Wen Cheng; Zhifeng Wei; Jianping Gao; Zhengyu Zhang; Jingping Ge; Kangzhen Jing; Feng Xu; Peng Xie
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-06-17

Review 3.  Intravesical treatments of bladder cancer: review.

Authors:  Zancong Shen; Tong Shen; M Guillaume Wientjes; Michael A O'Donnell; Jessie L-S Au
Journal:  Pharm Res       Date:  2008-03-28       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.